Skip to main content
. 2016 Jul 19;7(37):59471–59481. doi: 10.18632/oncotarget.10697

Figure 2. Gy1 can specifically bind and internalize into PSMA positive cancer cells.

Figure 2

A. Flow cytometry analysis to show the PSMA expression on different prostate cancer cells. B. Flow cytometry analysis to show the binding of gy1 to PSMA positive cancer cells. LNCaP, C4-2, PC3-PSMA+and PC3-PSMA cells were incubated with 100 nM of gy1 and followed by FITC-conjugated secondary antibody. NCP1 was used as negative control. C. Cellular ELISA to show the binding affinity of gy1. The Kd was calculated using non-linear regression analysis of a one-site binding hyperbola equation of GraphPad Prism 5.0 software. Representative result was shown from 3 independent experiments. D. Immunofluorescence staining to show the internalization of gy1 into PSMA positive cancer cells. Gy1 was incubated with LNCaP, C4-2, PC3-PSMA+ and PC3-PSMA cells for 2 h before immunofluorescence staining. Scale bar = 25 μm.

HHS Vulnerability Disclosure